Market Overview:
The global multiple sclerosis therapies market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of multiple sclerosis, rising awareness about available treatments, and technological advancements in the field of MS therapies. The global multiple sclerosis therapies market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into drug treatment and physical therapy. Drug treatment dominates this market owing to its high efficacy rates as compared to other treatments options available for MS patients. By application, hospital dominates this market due to better reimbursement scenario for hospital-based procedures as compared clinic-based procedures across different geographies covered in this study.
Product Definition:
Multiple sclerosis therapies are treatments used to manage the symptoms of multiple sclerosis (MS). MS is a chronic and progressive neurological disorder that affects the brain and spinal cord. Symptoms can vary from person to person, and may include problems with vision, balance, movement, thinking, and speech. There is no cure for MS, but there are a number of therapies available that can help manage its symptoms. These therapies include medications such as disease-modifying drugs (DMDs), rehabilitation therapies such as physical therapy or occupational therapy, lifestyle modifications such as diet or exercise programs, and complementary and alternative treatments such as acupuncture or meditation. The goal of treatment is to reduce the number of relapses a person experiences, improve their quality of life by managing their symptoms effectively, and slow down the progression of the disease.
Drug Treatment:
Drug treatment in multiple sclerosis therapeutics market is used to reduce the frequency and severity of attacks by modifying the immune response. The drug treatments are divided into two types: First-line therapy and second- or third-line therapy. First line therapies include interferon, glatiramer acetate (Copaxone), natalizumab (Tysabri), and rituximab (Rituxan).
Physical Therapy:
Physical therapy is a rehabilitation service that helps patients recover from the effects of neurological diseases and injuries through the application of physical activity. Physical activities include movements, such as walking, running, balancing, and manipulation techniques that are used to improve body movement. It also includes non-movement activities like breathing exercises & relaxation techniques.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. This is due to the increasing prevalence of multiple sclerosis and growing awareness about treatment options among patients, resulting in high demand for therapies outside hospitals and clinics. For instance, according to a study published by National MS Society Canada, out of 619 patients surveyed across Canada during 2016-2017, around 54% had visited a alternative medicine practitioner (AMP) for their condition while 29% had consulted an osteopath/osteopathic doctor (OD) regarding management of their symptoms. Increasing number of such studies will help market players to design effective communication strategies that target consumers directly through AMPs or ODs with relevant information related to Multiple Sclerosis treatments.
Regional Analysis:
North America dominated the global multiple sclerosis therapeutics market in 2017. This can be attributed to the presence of key players, high disease prevalence, and availability of novel drugs. In addition, increasing government funding for R&D activities is also expected to drive growth during the forecast period. For instance, in 2016 U.S.-based company Biogen Inc., received USD X million funding from National Institute of Health (NIH) for research on multiple sclerosis therapy development program called Accelerating Innovation Project (AIP).
Growth Factors:
- Increasing incidence of multiple sclerosis (MS)
- Growing awareness about MS and its treatment options
- Rising demand for novel and more effective therapies for MS
- Availability of government funding for MS research and development
- Technological advancements in the field of MS therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Multiple Sclerosis Therapies Market Research Report
By Type
Drug Treatment, Physical Therapy
By Application
Hospital, Clinic, Others
By Companies
Bayer, Biogen, Bristol Myers Squibb, Roche, GSK, Merck Group, Novartis, Teva Pharmaceutical Industries, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Multiple Sclerosis Therapies Market Report Segments:
The global Multiple Sclerosis Therapies market is segmented on the basis of:
Types
Drug Treatment, Physical Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Biogen
- Bristol Myers Squibb
- Roche
- GSK
- Merck Group
- Novartis
- Teva Pharmaceutical Industries
- Sanofi
Highlights of The Multiple Sclerosis Therapies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Treatment
- Physical Therapy
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Multiple Sclerosis Therapies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Multiple sclerosis (MS) therapies are treatments that aim to improve the symptoms of MS. These treatments can include medications, physical therapy, and surgery.
Some of the major players in the multiple sclerosis therapies market are Bayer, Biogen, Bristol Myers Squibb, Roche, GSK, Merck Group, Novartis, Teva Pharmaceutical Industries, Sanofi.
The multiple sclerosis therapies market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Multiple Sclerosis Therapies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Multiple Sclerosis Therapies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Multiple Sclerosis Therapies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Multiple Sclerosis Therapies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Multiple Sclerosis Therapies Market Size & Forecast, 2020-2028
4.5.1 Multiple Sclerosis Therapies Market Size and Y-o-Y Growth
4.5.2 Multiple Sclerosis Therapies Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Drug Treatment
5.2.2 Physical Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Multiple Sclerosis Therapies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Multiple Sclerosis Therapies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Drug Treatment
9.6.2 Physical Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Drug Treatment
10.6.2 Physical Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Drug Treatment
11.6.2 Physical Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Drug Treatment
12.6.2 Physical Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Drug Treatment
13.6.2 Physical Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Multiple Sclerosis Therapies Market: Competitive Dashboard
14.2 Global Multiple Sclerosis Therapies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Biogen
14.3.3 Bristol Myers Squibb
14.3.4 Roche
14.3.5 GSK
14.3.6 Merck Group
14.3.7 Novartis
14.3.8 Teva Pharmaceutical Industries
14.3.9 Sanofi
